FLUAD® vs. Fluzone® High-Dose Study

PHASE4CompletedINTERVENTIONAL
Enrollment

757

Participants

Timeline

Start Date

August 28, 2017

Primary Completion Date

February 14, 2019

Study Completion Date

February 14, 2019

Conditions
PainQuality of LifeInjection Site ReactionSide Effect of DrugAdverse Drug Event
Interventions
BIOLOGICAL

FLUAD®

Advisory Committee on Immunization Practices (ACIP) Recommended Vaccine

BIOLOGICAL

Fluzone® High-Dose

Advisory Committee on Immunization Practices (ACIP) Recommended Vaccine

Trial Locations (4)

27705

Duke University, Durham

30333

Centers for Disease Control and Prevention, Atlanta

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

02118

Boston Medical Center, Boston

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Centers for Disease Control and Prevention

FED

collaborator

Boston Medical Center

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

lead

Duke University

OTHER

NCT03183908 - FLUAD® vs. Fluzone® High-Dose Study | Biotech Hunter | Biotech Hunter